I've been keeping an eye on Kewaunee Scientific Corporation (NASDAQ:KEQU) because I'm attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe KEQU has a lot to offer. Basically, it is a highly-regarded dividend payer that has been able to sustain great financial health over the past. Below is a brief commentary on these key aspects. For those interested in digger a bit deeper into my commentary, read the full report on Kewaunee Scientific here.
Flawless balance sheet average dividend payer
KEQU's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This implies that KEQU manages its cash and cost levels well, which is an important determinant of the company’s health. KEQU appears to have made good use of debt, producing operating cash levels of 1.22x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.
Income investors would also be happy to know that KEQU is a great dividend company, with a current yield standing at 3.5%. KEQU has also been regularly increasing its dividend payments to shareholders over the past decade.
For Kewaunee Scientific, I've put together three important aspects you should further research:
- Future Outlook: What are well-informed industry analysts predicting for KEQU’s future growth? Take a look at our free research report of analyst consensus for KEQU’s outlook.
- Historical Performance: What has KEQU's returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of KEQU? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.